Key result
Postoperative highly fluorescent immature platelet fraction ≥0.95% was independently associated with serious complications after neurosurgery (OR 1.97; 95% CI 1.03-3.78; p=0.041).
Why the study?
Immature platelets possess increased prothrombotic potential, but whether they are associated with relevant complications in neurosurgical patients remained to be evaluated.
Is highly fluorescent immature platelet fraction (H-IPF) associated with serious postoperative complications in neurosurgical patients?
Observational (n=391)
Is highly fluorescent immature platelet fraction (H-IPF) associated with serious postoperative complications in neurosurgical patients?
Elevated postoperative highly fluorescent immature platelet fraction (H-IPF ≥0.95%) is independently associated with serious complications following neurosurgery.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for postoperative H-IPF monitoring in neurosurgery; leaves open prospective validation and clinical utility.
Immature platelets are newly formed platelets with an increased prothrombotic potential. This study evaluates whether immature platelets are associated with relevant complications in neurosurgical patients. Data were obtained in the frame of a prospectively conducted observational study exploring the association between immature platelets and major cardiovascular events after surgery. Immature platelet fraction (IPF) and H-IPF (highly fluorescent immature platelet fraction) were measured preoperatively and postoperatively at the neurosurgical ward (24–72 hours after surgery). Therapy-relevant complications after surgery were stratified using the Clavien-Dindo Grade (CDG >2) as primary outcome. Data were analyzed in 391 neurosurgical patients. While preoperatively there were no differences in IPF or H-IPF, patients with higher therapy-complication grades had higher values post-op compared to patients with lower grade complications (≤2 CDG). Cut-off values identified by receiver operating characteristic curve analysis revealed that there were significantly more patients with H-IPF ≥0.95% in the group with serious complications (CDG >2) [odds ratio OR (95% confidence interval CI) = 2.06 (1.09–3.9), p = .025], whereas this association was not present for the IPF cutoff value. In a multivariate model, H-IPF≥0.95% was independently associated with serious complications after surgery [OR (95% CI) = 1.97 (1.03–3.78), p = .041]. These findings suggest that H-IPF is associated with surgical complications and may improve risk stratification of neurosurgical patients (clinicaltrials.gov: NCT02097602, registration date: 27/03/2014).
No takes yet. Share an insight, caveat, or question.
Anetsberger et al. (2023) conducted an observational in Neurosurgical patients (n=391). Highly fluorescent immature platelet fraction (H-IPF) ≥0.95% vs. H-IPF <0.95% was evaluated on Therapy-relevant complications after surgery (Clavien-Dindo Grade >2) (OR 1.97, 95% CI 1.03-3.78, p=0.041). Postoperative highly fluorescent immature platelet fraction ≥0.95% was independently associated with serious complications after neurosurgery (OR 1.97; 95% CI 1.03-3.78; p=0.041).
Synapse has enriched 10 related papers. Consider them for comparative context: